TuesdayMar 14, 2023 11:19 am

QualityStocksNewsBreaks — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Fourth-Quarter, Year-End 2022 Report

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, has released numbers for Q4 and year-end 2022, both for the period ending Dec. 31, 2022. Highlights of the report included MUX subsidiary McEwen Copper completing three tranches of financing, raising $81.9 million in total; production of 133,300 gold equivalent ounces; and the company’s Fox Complex and Gold Bar mines generating a cash gross profit of $19.2 million in 2022 and a gross loss of $0.5 million. In addition, the report noted that MUX had consolidated net loss in 2022 of $81.1 million, or…

Continue Reading

TuesdayMar 14, 2023 11:15 am

GeoSolar Technologies Inc. Helping Make “Green Energy” a Reality for Everyone

Owing to a litany of drivers, the days of “green” or “alternative” energy will be terms of the past, replaced by simply “energy” as they are the standard GeoSolar Technologies is pioneering the home energy transition with its solar-based, all-electric, high-efficiency home model Transitioning homes in the U.S. to GeoSolar’s SmartGreen(TM) homes would be equivalent to removing about 65% of the country’s gas-powered vehicles as far as carbon emissions “As one era ends, another is just getting started – and we can’t wait to show you what we’ve got coming.” That was a tweet a few weeks ago from Ford…

Continue Reading

TuesdayMar 14, 2023 11:15 am

DGE’s 3rd Risk Based Quality Management Summit to Integrate Quality into Clinical Trials and Ensure Effective Monitoring

Clinical research executives, data management specialists, and industry experts, are all invited to attend the 3rd Risk Based Quality Management Summit that will be held from April 25-26, 2023 at the Le Méridien, in Philadelphia. The summit will be focused on conferring the details of executing data flow process maps, data monitoring tools, audit trails, and quality tolerance limits. RBQM is now being embraced to address the significant increase in research duration, cost, and complexity of clinical research. The newest version of the Good Clinical Practice (“GCP”) quality standard extends the RBM approach to every facet of study execution, implementing…

Continue Reading

TuesdayMar 14, 2023 9:45 am

SideChannel Inc. (SDCH), Virgin Voyages Extend Engagement, Adding Virtual Chief Privacy Officer Services to Help Safeguard Data and Information

SideChannel is committed to creating robust and top-tier cybersecurity programs for small and mid-market businesses (“SMBs”), thus helping them protect vital information and customers One of the companies SideChannel has helped achieve this goal is Virgin Voyages, which has expanded its engagement with SideChannel to improve its data privacy efforts with the addition of a virtual chief privacy officer (“vCPO”) from SideChannel The move builds on an earlier engagement, bolstering Virgin Voyages’ goal to protect the important information relating to its crew, sailors, and partners A recent study by IBM Corp. (NYSE: IBM) revealed that the average cost of a…

Continue Reading

TuesdayMar 14, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes

Lexaria’s DIAB-A22-1 animal model study just concluded, highlighting three positive outcomes, including an improvement in general activity, significant reductions in body weight, and improved triglyceride and cholesterol levels The study was undertaken by a third-party testing laboratory in Canada involving 24 obese and eight lean rats for a total of 32 male Zucker rats The success of this DIAB-A22-1 study marks a significant milestone for Lexaria, even as it continues to explore its patented DehydraTECH(TM) technology application in various other areas, including nicotine replacement, epilepsy, hypertension, dementia and more With its unique product offering, a growing list of patents, and…

Continue Reading

MondayMar 13, 2023 2:46 pm

QualityStocksNewsBreaks – Prime Harvest Inc. Secures Reg A+ Qualification, Eyes New Heights of Opportunity

Prime Harvest, a technology focused, full-service cannabis company, recently announced that its Regulation A+ offering, which seeks to raise up to $42 million, had been qualified by the U.S. Securities and Exchange Commission (“SEC”). “The company has announced that gross proceeds from the equity raising will be destined towards the acquisition of licensed assets, the development of Prime Harvest’s direct-to-consumer application, expansion of the company’s state-wide delivery capabilities, as well as general corporate purposes,” a recent article reads. “Dating back to the company’s change in corporate strategy in 2019, a move which saw Prime Harvest transition from its origins as…

Continue Reading

MondayMar 13, 2023 2:30 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) On Track to Advance Innovative Products

HeartBeam (NASDAQ: BEAT) is a cardiac technology company dedicated to finding effective ways to detect heart attacks earlier than ever before. “The company has two patented products in development: HeartBeam AIMI(TM), software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack more accurately; and HeartBeam AIMIGo(TM), the first and only credit-card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system to facilitate remote heart attack detection,” a recent article reads. “Although HeartBeam AIMI and HeartBeam AIMIGo have not yet been cleared by the U.S.…

Continue Reading

MondayMar 13, 2023 12:21 pm

QualityStocksNewsBreaks – Iconic Brands Inc. (ICNB) Announces Listing on OTCQB Market

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today announced that it regained compliance with OTC Markets and is listed on the OTCQB under the ticker symbol ICNB. “We are happy to announce that we have regained compliance with OTCQB Markets,” said Richard DeCicco, chairman of the board and president of Iconic. “The complete integration of our sustainable packaging business is a significant achievement for our company, and we are proud to demonstrate our commitment to our stockholders and investors in regaining our listing status with the OTC Markets. 2023 should…

Continue Reading

MondayMar 13, 2023 11:51 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Peer-Reviewed Study Results Published

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has announced that results of its study have been published in the “International Journal of Molecular Sciences.” The study was designed to evaluate the anti-inflammatory effects of rare cannabinoids and their potential application for the treatment of skin conditions, including atopic dermatitis, psoriasis, pruritus and acne. The study is titled “Rare Phytocannabinoids Exert Anti-Inflammatory Effects on Human Keratinocytes via the Endocannabinoid System and MAPK Signalling Pathway.” According to the announcement, study results demonstrate the therapeutic potential of rare cannabinoids in the…

Continue Reading

MondayMar 13, 2023 11:34 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces It Has No Exposure to Silicon Valley Bank Issues

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that it is aware that the Federal Deposit Insurance Corp. has taken control of Silicon Valley Bank (“SVB”) due to liquidity concerns. CNS Pharmaceuticals does not hold any deposits or investments at SVB. To view the full press release, visit https://ibn.fm/1EM7p About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered